• Sat. Sep 30th, 2023

A Preview Of Catalyst Pharmaceuticals’ Earnings

ByBenzinga Insights

Aug 8, 2022
A Preview Of Catalyst Pharmaceuticals' Earnings


Catalyst Pharmaceuticals CPRX is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here’s what investors need to know before the announcement.

Analysts estimate that Catalyst Pharmaceuticals will report an earnings per share (EPS) of $0.17.

Catalyst Pharmaceuticals bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.02, which was followed by a 6.06% drop in the share price the next day.

Here’s a look at Catalyst Pharmaceuticals’s past performance and the resulting price change:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.14 0.12 0.1 0.09
EPS Actual 0.12 0.09 0.1 0.11
Price Change % -6.06% -6.34% 4.54% 3.12%

Stock Performance

Shares of Catalyst Pharmaceuticals were trading at $11.13 as of August 05. Over the last 52-week period, shares are up 82.24%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Catalyst Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Image and article originally from www.benzinga.com. Read the original article here.